DK211483D0 - Fremgangsmade til fremstilling af a-og b-underenhederne af koleratoksin og beslaegtede dna-sekvenser og rekombinerede dna-molekyler - Google Patents

Fremgangsmade til fremstilling af a-og b-underenhederne af koleratoksin og beslaegtede dna-sekvenser og rekombinerede dna-molekyler

Info

Publication number
DK211483D0
DK211483D0 DK2114/83A DK211483A DK211483D0 DK 211483 D0 DK211483 D0 DK 211483D0 DK 2114/83 A DK2114/83 A DK 2114/83A DK 211483 A DK211483 A DK 211483A DK 211483 D0 DK211483 D0 DK 211483D0
Authority
DK
Denmark
Prior art keywords
coleratoxin
recombinated
substances
preparing
procedure
Prior art date
Application number
DK2114/83A
Other languages
English (en)
Other versions
DK211483A (da
Inventor
Nigel Harford
Michel De Wilde
Original Assignee
Smith Kline Rit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline Rit filed Critical Smith Kline Rit
Publication of DK211483D0 publication Critical patent/DK211483D0/da
Publication of DK211483A publication Critical patent/DK211483A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/848Escherichia
    • Y10S435/849Escherichia coli
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/909Vibrio

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK211483A 1982-05-24 1983-05-11 Fremgangsmaade til fremstilling af a- og b-underenhederne af koleratoksin og beslaegtede dna-sekvenser og rekombinerede dna-molekyler DK211483A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/381,083 US4666837A (en) 1982-05-24 1982-05-24 DNA sequences, recombinant DNA molecules and processes for producing the A and B subunits of cholera toxin and preparations containing so-obtained subunit or subunits

Publications (2)

Publication Number Publication Date
DK211483D0 true DK211483D0 (da) 1983-05-11
DK211483A DK211483A (da) 1983-11-25

Family

ID=23503587

Family Applications (1)

Application Number Title Priority Date Filing Date
DK211483A DK211483A (da) 1982-05-24 1983-05-11 Fremgangsmaade til fremstilling af a- og b-underenhederne af koleratoksin og beslaegtede dna-sekvenser og rekombinerede dna-molekyler

Country Status (10)

Country Link
US (1) US4666837A (da)
EP (1) EP0095452A3 (da)
JP (1) JPS58222033A (da)
AU (1) AU1348083A (da)
CA (1) CA1212640A (da)
DK (1) DK211483A (da)
ES (3) ES8504458A1 (da)
GR (1) GR79261B (da)
PT (1) PT76726B (da)
ZA (1) ZA833662B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470729A (en) * 1983-03-04 1995-11-28 University Of Maryland At Baltimore Method of isolating restriction fragment deletions in Vibrio cholerae, and products thereof
US4935364A (en) * 1983-03-04 1990-06-19 Swiss Serum And Vaccine Institute Berne Method of isolating restriction fragment deletions in vibrio cholerae and products thereof
US5882653A (en) * 1983-03-04 1999-03-16 The University Of Maryland System Vibrio cholerae 01 (CVD111) and non-01 (CVD112 and CVD112RM) serogroup vaccine strains, methods of making same and products thereof
US5399494A (en) * 1983-03-04 1995-03-21 The University Of Maryland System Vibrio cholerae strain CVD103Hgr, method of making same, and vaccines derived therefrom
US4882278A (en) * 1983-04-29 1989-11-21 President And Fellows Of Harvard College Non-toxinogenic vibrio cholerae mutants
GB8333131D0 (en) * 1983-12-12 1984-01-18 Glaxo Group Ltd Microbiological process
IT1217303B (it) * 1984-02-01 1990-03-22 Enterovax Res Pty Ltd Ceppi batterici particolarmente utili per la produzione di vaccini per il trattamenmto di malattie intestinali e simili e metodo di ingegneria gentica per la produzione dei detti vaccini
US5668255A (en) * 1984-06-07 1997-09-16 Seragen, Inc. Hybrid molecules having translocation region and cell-binding region
US6022950A (en) * 1984-06-07 2000-02-08 Seragen, Inc. Hybrid molecules having translocation region and cell-binding region
US4808700A (en) * 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
US5308835A (en) * 1984-07-09 1994-05-03 Praxis Biologics, Inc. Production of the E. coli LT-B enterotoxin subunit
CA1340372C (en) * 1984-07-09 1999-02-02 John D. Clements Production of e. coli lt-b enterotoxin subunit
US5091513A (en) * 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5132405A (en) * 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
JPH02500329A (ja) * 1987-05-21 1990-02-08 クリエイテイブ・バイオマリキユールズ・インコーポレーテツド ターゲット化多機能蛋白質
US5258498A (en) * 1987-05-21 1993-11-02 Creative Biomolecules, Inc. Polypeptide linkers for production of biosynthetic proteins
US6043057A (en) * 1988-09-16 2000-03-28 Vitec Aktiebolag Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides
SE462285B (sv) * 1988-09-16 1990-05-28 Jan Roland Holmgren Expression av koleratoxinets bindande subenhet med hjaelp av fraemmande promotor- och/eller ledarpeptidstrukturer
FR2636842B1 (fr) * 1988-09-27 1994-06-10 Liege Universite Etat Proteine de fusion d'une sequence derivee de la sous-unite b de la toxine cholerique et d'un antigene heterologue doue de proprietes immunogenes, compositions de vaccins les contenant et acides nucleiques recombinants contenant une sequence de nucleotides codant pour ladite proteine de fusion
US5985327A (en) * 1988-10-05 1999-11-16 Flinders Technologies Pty. Ltd. Solid medium and method for DNA storage
US20040014068A1 (en) * 1988-10-05 2004-01-22 Whatman, Inc. Solid medium and method for DNA storage
WO1991009871A1 (en) * 1989-12-22 1991-07-11 Seragen Incorporated Hybrid molecules having translocation region and cell-binding region
IL101715A (en) * 1991-05-02 2005-06-19 Amgen Inc Recombinant dna-derived cholera toxin subunit analogs
GB9513371D0 (en) * 1995-06-30 1995-09-06 Biocine Spa Immunogenic detoxified mutant toxins
IT1253009B (it) * 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
USH1985H1 (en) 1992-01-09 2001-08-07 The United States Of America As Represented By The Secretary Of The Navy Method for detecting biological toxins
JP3134907B2 (ja) * 1993-06-15 2001-02-13 株式会社島津製作所 コレラ菌検出用オリゴヌクレオチドおよびそれを用いた検出法
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
US20020032316A1 (en) * 1995-03-31 2002-03-14 Cantab Pharmaceuticals Research Limited Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
US5773003A (en) * 1995-03-31 1998-06-30 Immulogic, Inc. Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
AU5374996A (en) * 1995-03-31 1996-10-16 Cantab Pharmaceuticals Research Limited Hapten-carrier conjugates for use in drug-abuse therapy
US6818222B1 (en) 1997-03-21 2004-11-16 Chiron Corporation Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
US7097845B2 (en) 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
US6232082B1 (en) 1998-12-01 2001-05-15 Nabi Hapten-carrier conjugates for treating and preventing nicotine addiction
US20030162733A1 (en) * 2000-11-27 2003-08-28 Haynes Joel R. Nucleic acid adjuvants
EP2316482A1 (en) 2001-03-19 2011-05-04 Intercell USA, Inc. Transcutaneous immunostimulation
US20060099229A1 (en) * 2004-11-05 2006-05-11 Universiti Sains Malaysia Vibrio cholerae strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof
WO2014044690A1 (en) 2012-09-18 2014-03-27 Valneva Austria Gmbh Improved vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) * 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US4264737A (en) * 1978-09-21 1981-04-28 President And Fellows Of Harvard College Method of making genetically stable mutants of vibrio cholerae
US4332892A (en) * 1979-01-15 1982-06-01 President And Fellows Of Harvard College Protein synthesis
US4328209A (en) * 1979-04-11 1982-05-04 Board Of Regents, The University Of Texas System Cholera vaccine
US4293652A (en) * 1979-05-25 1981-10-06 Cetus Corporation Method for synthesizing DNA sequentially
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis

Also Published As

Publication number Publication date
ES529276A0 (es) 1985-05-01
DK211483A (da) 1983-11-25
ES8504460A1 (es) 1985-05-01
JPS58222033A (ja) 1983-12-23
GR79261B (da) 1984-10-22
CA1212640A (en) 1986-10-14
PT76726B (en) 1985-12-27
ZA833662B (en) 1984-03-28
AU1348083A (en) 1983-12-01
ES8506348A1 (es) 1985-07-01
ES522566A0 (es) 1985-04-16
EP0095452A2 (fr) 1983-11-30
EP0095452A3 (en) 1985-10-02
ES8504458A1 (es) 1985-04-16
US4666837A (en) 1987-05-19
ES535809A0 (es) 1985-07-01
PT76726A (en) 1983-06-01

Similar Documents

Publication Publication Date Title
DK211483D0 (da) Fremgangsmade til fremstilling af a-og b-underenhederne af koleratoksin og beslaegtede dna-sekvenser og rekombinerede dna-molekyler
DK30283A (da) Materialer og fremgangsmaade til fremstilling af dialyseoploesninger indeholdende bicarbonationer
DK162124C (da) Maerkede nucleinsyresonder og addukter til fremstilling heraf
DK158585D0 (da) Fremgangsmaade til fremstilling af streptococcus-m-protein-immunogener og molekylarsonder
DK40086A (da) Formaldehyd-bindemiddel, fremgangsmaade til fremstilling deraf og anvendelse deraf
DK117887A (da) Apparat til presning og formning af ostemasse
DK164486D0 (da) Molekylaert orienteret formstofnet og fremgangsmaade til fremstilling af dette
DK378388A (da) Fremgangsmaade og apparat til fremstilling af pyramidestubformede daaseemner
DK161671C (da) Apparat til behandling af vaesker
DK40887A (da) Apparat og fremgangsmaade til pumpning af en vaeske
DK371180A (da) Fremgangsmaade og apparat til fremstilling af formlegemer af termoplastisk formstof
IS2700A7 (is) Efni afleidd af Pyrrolidin og aðferð til framleiðslu þeirra
DK149385D0 (da) Apparat og fremgangsmaade til fremstilling af ispinde
DK151424C (da) Kondensator og fremgangsmaade og apparat til fremstilling af denne
DK229888D0 (da) Fremgangsmaade og indretning til udlaegning af plastroer
DK482583D0 (da) Dna-sekvens, dna-strukturer og fremgangsmade til fremstilling af penicillin-acylase under anvendelse deraf
DK86586A (da) Fremgangsmaade og apparatur til beroeringsfri detektering af vaekster
DK6888D0 (da) Fremgangsmaade og apparat til forbedring af en trykkammermoelles formalingsresultat
DK36891A (da) Fremgangsmaade og apparatur til fremstilling af trykplader
DK243885D0 (da) Fremgangsmaade til fremstilling af stoebeforme og maskine til udoevelse af fremgangsmaaden
DK162475C (da) Terapeutisk praeparat indeholdende hydrogenerede ergotalkaloider og heparin og fremgangsmaade til fremstiling af praeparatet
IS2742A7 (is) Efni afleidd af Pyrrolidin og aðferð til framleiðslu þeirra
DK435283D0 (da) Diastereomerer og fremgangsmade til fremstilling deraf
DK35981A (da) Binding af plastmaterialer og apparat til at klargoere plastmaterialer til binding
DK212989D0 (da) Apparat og fremgangsmaade til oparbejdning af mineralske taetningsstoffer

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment